SCHEMBL6166177

SCHEMBL6166177

CN(C)NC(=O)Nc1ccc2c(c1)C(c1cccs1)=CC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA P10276 3/20 0.42
RARB P10826 3/20 0.42
CDK4 P11802 1/20 0.39
CCND1 P24385 1/20 0.39
MAPT P10636 14/20 0.38
MEN1 O00255 7/20 0.38
KMT2A Q03164 7/20 0.38
KDM4E B2RXH2 7/20 0.38
ALDH1A1 P00352 6/20 0.38
LMNA P02545 4/20 0.38
HTT P42858 3/20 0.38
RAB9A P51151 6/20 0.36
NPC1 O15118 5/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
GAA P10253 6/20 0.35
HSD17B10 Q99714 5/20 0.35
TP53 P04637 5/20 0.35
ALOX15 P16050 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168298 0.78 PTPN7 (0.40) CDK4CCND1MAPTMEN1KMT2A
SCHEMBL6173033 0.72 NQO2 (0.41) MAPTKDM4ERAB9ANPC1MAPK1
SCHEMBL2973403 0.71 KMT2A (0.38) RARARARBMAPTMEN1KMT2A
SCHEMBL2964041 0.63 CYP3A4 (0.38) RARARARBMAPTMEN1KMT2A
SCHEMBL12365037 0.62 RARA (0.48) RARARARBMAPTMEN1KMT2A
SCHEMBL8613812 0.61 KDM4E (0.65) MAPTMEN1KMT2AKDM4ERAB9A
SCHEMBL12365056 0.60 RARA (0.49) RARARARBMEN1KMT2AALDH1A1
SCHEMBL4033332 0.60 ALDH1A1 (0.50) MAPTKMT2AKDM4EALDH1A1LMNA
SCHEMBL13102959 0.60 RAB9A (0.59) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL30949383 0.59 NPC1 (0.59) MAPTMEN1KMT2AKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1417177-A4 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL MYERS SQUIBB PHARMA CO (US) 2005-10-19 EP disclosed
EP-1417177-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Bristol-Myers Squibb Pharma Company (US) 2004-05-12 EP disclosed
WO-2003007883-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2003-01-30 WO disclosed